M Financial Group has partnered with GRAIL, a healthcare company based in Menlo Park, California, to offer GRAIL’s multi-cancer early-detection test, Galleri, to qualified clients of M Member Firms.
The Galleri multi-cancer early detection test detects a cancer signal across more than 50 types of cancer, many of which are not commonly screened for today, through a single blood draw. The Galleri test does not diagnose cancer, and not all cancers may be detected in the blood.*
“I’m excited that M Financial and our Member Firms are on the forefront of healthcare innovation by offering our clients a true breakthrough in cancer detection science,” said Andy Graves, M’s VP, Head of Member Firm Development. “This partnership further exemplifies M’s commitment to serving our clients’ best interests. By providing access to this technology, we have the incredible potential to help our clients live longer, fuller lives.”
To learn more about M Financial’s partnership with GRAIL to offer the Galleri test, please visit the M Financial page on the Galleri website.
*The Galleri test does not detect all cancers, nor does it measure the genetic risk of developing cancer in the future. It should be used in addition to, and not replace, routine screening tests recommended by a healthcare provider. Please review the M Financial page on the Galleri website for eligibility requirements, safety information, and other FAQ.
With more than 130 Member Firms in 36 states and the United Kingdom, M Financial Group is one of the nation’s leading financial services design and distribution companies. Since 1978, M Financial’s network of independent insurance and executive benefit firms has served the needs of high-net-worth individuals, corporate executives, successful entrepreneurs, and Fortune 1000 companies.
For more information, please contact TV Kumaresh, Chief Strategy Officer, at tv.kumaresh@mfin.com or visit our website at www.mfin.com.
